Le Lézard
Classified in: Health
Subjects: MAV, CCA, FVT

Notice of Medical Facilities Corporation's 2019 First Quarter Financial Results Conference Call and Webcast


TORONTO, April 25, 2019 /CNW/ - Medical Facilities Corporation ("Medical Facilities") (TSX: DR) will release its 2019 first quarter financial results prior to market open on Thursday, May 9, 2019. Following the release, management will host a conference call at 8:30 a.m. ET to review the financial results.

All interested parties are invited to participate. Please dial 647-427-7450 or 1-888-231-8191 15 minutes prior to the call to secure a line. You will be put on hold until the conference call begins.

A question-and-answer session will follow the conference call, at which time the operator will provide instructions for submitting questions. A replay of the conference call will also be available until 11:59 p.m. ET, Thursday, May 16, 2019 by calling 416-849-0833 or 1-855-859-2056, reference number 2892579.

A live audio webcast of the call will be available at http://bit.ly/MFC2019Q1. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. The webcast will be archived on Medical Facilities' website following the call date.

Medical Facilities' financial statements and management's discussion and analysis for the three-month period ended March 31, 2019 will be filed on SEDAR at www.sedar.com following the release and will be available on the same day on Medical Facilities' website at www.medicalfacilitiescorp.ca.

About Medical Facilities Corporation

Medical Facilities, in partnership with physicians, owns surgical facilities in the United States. Medical Facilities' portfolio includes controlling interest in five specialty surgical hospitals located in Arkansas, Indiana, Oklahoma, and South Dakota, and an ambulatory surgery center located in California. In addition, through a partnership with NueHealth LLC, Medical Facilities owns controlling interest in seven ambulatory surgery centers located in Arkansas, Michigan, Missouri, Nebraska, Ohio, Oregon, and Pennsylvania. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ambulatory surgery centers specialize in outpatient surgical procedures, with patient stays of less than 24 hours. Medical Facilities is structured so that a majority of its free cash flow from operations is distributed to the holders of its common shares in the form of dividends. For more information, please visit www.medicalfacilitiescorp.ca.

SOURCE Medical Facilities Corporation


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: